Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery
ACTRN12610000550000Phase 4Not yet recruiting
- Sponsor
- milton gomez
- Start
- Jul 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of carbetocin and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by milton gomez. Primary endpoint: Average postpartum bleeding within 24 hours. Planned start Jul 2010; status: not yet recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12610000550000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000550000.